2D-QSAR Studies on Unsaturated 4-Azasteroids as 5α-reductase Inhibitors
Abstract
Abstract
Dihydrotestosterone (DHT) a major circulating male hormone is produced by NADPH dependent enzyme 5α-reductase (5 alpha R) and has been found to be causative agent in the development of pathological condition i.e. benign prostate hyperplasia (BPH). Thus inhibition of 5α-reductase enzyme represents a novel target in the treatment of BPH. Present study describes the relationship between the 5α-Reductase inhibitory activity for structurally related unsaturated 4-azasteroids derivatives and their physicochemical descriptors in quantitative terms. Using Vlife molecular design suits (MDS), LOO validated 2D-QSAR model has been developed with statistical data r2 = 0.8706, q2 =0.7122 , F = 14.5758, pred r2 = 0.7441. Descriptor with positive and negative correlation with the biological activity has been highlighted. This validated 2D-QSAR model may be used to design 5α-Reductase derivatives with better inhibitory properties.
Graphical Abstract
pIC50 = +0.0094(Quadrupole1)-0.2285(SssCH2E-index)-0.3929(chi4pathCluster)-0.0724(5PathCount)+0.0240(SA Hydrophilic Area)+5.3457(Id Average)-0.23550
Keywords: Dihydrotestosterone, benign prostatic hyperplasia, 5α-reductase inhibitors, 2D-QSAR, regression analysis, 4-azasteroids
Cite this Article
Priyanka Rana, Richa Dhingra, Monika et al. 2D-QSAR Studies on Unsaturated 4-Azasteroids as 5α-Reductase Inhibitors. Research & Reviews: A Journal of Drug Design & Discovery. 2017; 4(1): 26–37p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
